E-LIB Suche - Ergebnisse für: Pasello, G.

1

206P Liver kinase B1 expression is associated with improved..:

Maso, A. Dal ; Ferrarini, F. ; Esposito, G....
ESMO Open. 9 (2024) - p. 102779 , 2024

Link: https://doi.org/10.1016/..

2

53P MET exon 14 skipping mutations in non-small cell lung c..:

Reale, M.L. ; Passiglia, F. ; Cappuzzo, F....
ESMO Open. 9 (2024) - p. 102632 , 2024

Link: https://doi.org/10.1016/..

3

164P Circulating cytokines levels as predictive biomarkers ..:

Scattolin, D. ; Urso, L. ; Cavallari, I....
ESMO Open. 9 (2024) - p. 102740 , 2024

Link: https://doi.org/10.1016/..

4

123P Updated safety of perioperative durvalumab for resecta..:

Urban, L. ; Winder, T. ; Reck, M....
ESMO Open. 9 (2024) - p. 102702 , 2024

Link: https://doi.org/10.1016/..

5

MA18.09 Carboplatin, Etoposide, Bevacizumab, and Atezolizum..:

Lamberti, G. ; Rihawi, K. ; Riccardi, F....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S168-S169 , 2023

Link: https://doi.org/10.1016/..

6

164P Immune cells distribution and spatial relationship wit..:

Pasello, G. ; Lorenzi, M. ; Tosi, A....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S130-S131 , 2023

Link: https://doi.org/10.1016/..

7

EP11.01-01 Final Analysis of First-Line Chemo-Immunotherapy..:

Leonetti, A. ; Perrone, F. ; Puntoni, M....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S610 , 2023

Link: https://doi.org/10.1016/..

8

21P Bevacizumab plus atezolizumab and chemotherapy in NSCLC..:

Pasello, G. ; Lorenzi, M. ; Crivellaro, G....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S52-S53 , 2023

Link: https://doi.org/10.1016/..

9

P1.23-06 Liquid Biopsy Predicts Differential Benefit from F..:

Bonanno, L. ; Zulato, E. ; Del Bianco, P....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S257 , 2023

Link: https://doi.org/10.1016/..

10

EP02.04-001 Alectinib as Neoadjuvant Treatment in Surgicall..:

Leonetti, A. ; Minari, R. ; Boni, L....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S231 , 2022

Link: https://doi.org/10.1016/..

11

P1.15-06 Immune-Checkpoint Inhibitors-Related Colitis in Ad..:

Lorenzi, M. ; Massa, D. ; Angerilli, V....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S121-S122 , 2022

Link: https://doi.org/10.1016/..

12

EP08.01-007 Real-World Outcomes of Patients with Advanced L..:

F. Perrone, A. Leonetti ; Puntoni, M. ; Bordi, P....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S338-S339 , 2022

Link: https://doi.org/10.1016/..

13

Erratum to 'Evaluation of COVID-19 impact on DELAYing diagn..:

Cantini, L. ; Mentrasti, G. ; Lo Russo, G....
ESMO Open. 7 (2022) 2 - p. 100471 , 2022

Link: https://doi.org/10.1016/..

14

EP08.02-104 Osimertinib in Untreated EGFR-Mutant Non-small ..:

Lorenzi, M. ; Scattolin, D. ; Del Conte, A....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S450-S451 , 2022

Link: https://doi.org/10.1016/..

15

EP14.01-006 CeLEBrATE: Phase II trial of CarbopLatin, Etopo..:

Andrini, E. ; Lamberti, G. ; Mazzoni, F....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S528-S529 , 2022

Link: https://doi.org/10.1016/..